Genetic control of autoimmune diabetes in the NOD mouse.

LS Wicker, JA Todd, LB Peterson - Annual review of immunology, 1995 - europepmc.org
The nonobese diabetic (NOD) mouse is a model of human autoimmune insulin-dependent
diabetes mellitus. The NOD mouse also serves as a model for studying complex polygenic …

The genetics of complex autoimmune diseases: non-MHC susceptibility genes

A Wanstrat, E Wakeland - Nature immunology, 2001 - nature.com
Susceptibility to complex autoimmune diseases (AIDs) is a multigenic phenotype affected by
a variety of genetic and environmental or stochastic factors. After over a decade of linkage …

Redox regulation of m6A methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes

DF De Jesus, Z Zhang, NK Brown, X Li, L Xiao, J Hu… - Nature cell …, 2024 - nature.com
Abstract Type 1 diabetes (T1D) is characterized by the destruction of pancreatic β-cells.
Several observations have renewed the interest in β-cell RNA sensors and editors. Here, we …

Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses

QY Zheng, KR Johnson, LC Erway - Hearing research, 1999 - Elsevier
The common occurrence of hearing loss in both humans and mice, and the anatomical and
functional similarities of their inner ears, attest to the potential of mice being used as models …

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells

K Takenaka, TK Prasolava, JCY Wang… - Nature …, 2007 - nature.com
Graft failure in the transplantation of hematopoietic stem cells occurs despite donor-host
genetic identity of human leukocyte antigens, suggesting that additional factors modulate …

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes

P Fiorina, M Jurewicz, A Augello, A Vergani… - The journal of …, 2009 - journals.aai.org
Human clinical trials in type 1 diabetes (T1D) patients using mesenchymal stem cells (MSC)
are presently underway without prior validation in a mouse model for the disease. In …

Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity

JK Naggert, LD Fricker, O Varlamov, PM Nishina… - Nature …, 1995 - nature.com
Mice homozygous for the fat mutation develop obesity and hyperglycaemia that can be
suppressed by treatment with exogenous insulin. The fat mutation maps to mouse …

Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1 …

SW Christianson, LD Shultz, EH Leiter - Diabetes, 1993 - Am Diabetes Assoc
Precise definition of the role of both CD4 and CD8 T-cell subsets from NOD mice in the
adoptive transfer of diabetes has been complicated by the possibility that endogenous T …

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice

R Tisch, XD Yang, SM Singer, RS Liblau, L Fugger… - Nature, 1993 - nature.com
KNOWING the autoantigen target (s) in an organ-specific autoimmune disease is essential
to understanding its pathogenesis. Insulin-dependent diabetes mellitus (IDDM) is an …

Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes

AJ Lakhter, RE Pratt, RE Moore, KK Doucette, BF Maier… - Diabetologia, 2018 - Springer
Aims/hypothesis Improved biomarkers are acutely needed for the detection of developing
type 1 diabetes, prior to critical loss of beta cell mass. We previously demonstrated that …